Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News The Boeing Company BA

Boeing is a major aerospace and defense firm. It operates in four segments: commercial airplanes; defense, space & security; global services; and Boeing capital. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft ranging from 130 seats upwards. Boeing's defense, space & security segment competes with Lockheed, Northrop, and several other firms to create military aircraft and weaponry. Boeing global services provides aftermarket support to airlines.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NYSE:BA)

Fundamentals Snapshot (NYSE:BA)

Bullboard Posts (NYSE:BA)

RE:FED Blinks, Pivots, Twiches, Rolls Over and Copulates

Exited BA-N @ $214.74 to now hold NIL.
Contra_Man - 6 days ago

FED Blinks, Pivots, Twiches, Rolls Over and Copulates

Added as now filled fifteen (15) BA-N @ $207.51 to now hold 15/15 inventory allocation. Blondie's Bluff "The yield on Canada’s...
Contra_Man - 13 days ago

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

 
HarryPerkins - July 13, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >> FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets...
HarryPerkins - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

HarryPerkins - June 1, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

 
HarryPerkins - May 10, 2022